TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study
NCT02252354
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
[14C]-TAK-385 Oral Solution
DRUG:
TAK-385 Tablets
DRUG:
[14C]-TAK-385 Solution for Intravenous Infusion
Sponsor
Takeda